Evidence map›Paper›PMID 34235000›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2021

Exploratory study of

Akinyemi A Akintayo, Mehmet A Bilen, Olayinka A Abiodun-Ojo, Omer Kucuk, Bradley Carthon, Zengjia Chen, Ashesh B Jani, Ephraim E Parent, David M Schuster

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Radionuclides Landscape in Prostate Cancer Theranostics.International journal of molecular sciences · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Akinyemi A AkintayoDepartment of Radiology and Imaging Sciences, Emory University Hospital 1364 Clifton Road, Atlanta, GA 30322, USA.
Mehmet A BilenDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University Atlanta, GA, USA.
Olayinka A Abiodun-OjoDepartment of Radiology and Imaging Sciences, Emory University Hospital 1364 Clifton Road, Atlanta, GA 30322, USA.
Omer KucukDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University Atlanta, GA, USA.
Bradley CarthonDepartment of Radiation Oncology Emory University School of Medicine Atlanta, GA, USA.
Zengjia ChenDepartment of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health Atlanta, Georgia, USA.
Ashesh B JaniDepartment of Radiation Oncology Emory University School of Medicine Atlanta, GA, USA.
Ephraim E ParentDepartment of Radiology, Mayo Clinic Jacksonville, Florida, USA.
David M SchusterDepartment of Radiology and Imaging Sciences, Emory University Hospital 1364 Clifton Road, Atlanta, GA 30322, USA.
Emory University · USEmory University Hospital · USJacksonville College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monitoring therapeutic response in patients with metastatic castration-resistant prostate cancer (mCRPC) can be challenging. We set out to determine if

Indexed as

18F-fluciclovinedocetaxelmetastatic castration-resistant prostate cancerProstate cancertherapy response

Identifiers

PMID34235000
PMCPMC8255212
OpenAlexW3119830861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.